Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CANGRELOR for Product used for unknown indication: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 83 adverse event reports in the FDA FAERS database where CANGRELOR was used for Product used for unknown indication.

Most Reported Side Effects for CANGRELOR

Side Effect Reports % Deaths Hosp.
Off label use 144 44.6% 25 9
Vascular stent thrombosis 29 9.0% 4 1
Drug ineffective 26 8.1% 3 13
Haemorrhage 22 6.8% 6 5
Death 19 5.9% 19 0
No adverse event 19 5.9% 0 0
Inappropriate schedule of product administration 18 5.6% 5 3
Cardiac arrest 15 4.6% 8 0
Cardiogenic shock 14 4.3% 11 3
Gastrointestinal haemorrhage 12 3.7% 2 6
Intentional product use issue 11 3.4% 1 1
Drug ineffective for unapproved indication 9 2.8% 2 0
Dyspnoea 9 2.8% 1 0
Haemorrhage intracranial 9 2.8% 3 2
Vascular access site haemorrhage 9 2.8% 3 1

Other Indications for CANGRELOR

Percutaneous coronary intervention (94) Off label use (81) Antiplatelet therapy (41) Acute myocardial infarction (17) Stent placement (15) Thrombosis prophylaxis (12) Anticoagulant therapy (10) Coronary artery bypass (6)

Other Drugs Used for Product used for unknown indication

OXYCODONE (129,391) ADAPALENE (91,681) APIXABAN (88,417) ETANERCEPT (71,866) SACUBITRIL\VALSARTAN (69,693) ACETAMINOPHEN (68,427) AVOBENZONE\OCTISALATE\OCTOCRYLENE (65,206) ADALIMUMAB (63,549) EVOLOCUMAB (60,696) MORPHINE (59,440)

Related Pages

CANGRELOR Full Profile All Product used for unknown indication Drugs CANGRELOR Demographics CANGRELOR Timeline